Here are five key notes:
1. The financing round amounted to $21 million.
2. Redline Capital Management, a new investor, led the round, which included participation from all major investors.
3. The company will primarily use the proceeds to fund further United States and European expansion in anticipation of the increased demand for minimally invasive surgical SI joint fusion in these markets.
4. Proceeds will also be used to enter other markets, including the Middle East, Asia and South America.
5. The SI joint fusion market is expected to grow six-fold over the next three years.
More articles on orthopedic devices:
6 key trends in the North American joint reconstruction market
Orchid opens new India plant—5 things to know
8 trends in the China orthopedic instrument market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
